Metagenomi Therapeutics, Inc. (MGX) Insider Trading
Sector: Biotechnology · Market Cap: $38M · 0 insider purchases in the last 7 days
No open market insider purchases at Metagenomi Therapeutics, Inc. in the last 7 days.
Want more?
Sign up free to see 30+ days of history, set alerts, and track MGX on your watchlist.
Start for FreeAbout Metagenomi Therapeutics, Inc. Insider Trading
1 insider at Metagenomi Therapeutics, Inc. (MGX) has purchased stock in the past 90 days, totaling $23K across 2 transactions (20,000 shares).
The most recent purchase was by Director Reid Laurence on September 9, 2026 — a $23K buy of 19,883 shares at $1.17, bringing their total holdings to 19,883 shares.
This insider buying is notable given that MGX had no recorded open market purchases in the nine months before that.
MGX is in the Biotechnology sector within the Biotechnology industry with a market cap of $38M.
Track MGX insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.